04:38 PM EST, 02/20/2025 (MT Newswires) -- Guardant Health ( GH ) reported a Q4 adjusted loss late Thursday of $0.62 per diluted share, narrowing from the loss of $0.64 a year earlier.

Analysts polled by FactSet expected a loss of $0.49.

Revenue in the three months ended Dec. 31 rose to $201.8 million from $155.1 million a year earlier.

Analysts surveyed by FactSet expected $192.1 million.

In 2025, the company expects revenue of $850 million to $860 million. Analysts expect $846.3 million.